Showing results (1931-1940 of 2,221) with videos related to

Sort By:
Pageof 223
Frontiers in Psychiatry|March 23, 2011
Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects: a double-blind placebo controlled FMRI studyDavid Pincus, Samet Kose, Ashley Arana, et al.
Journal of Protein Chemistry|June 6, 2000
Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21L Chie, J M Chen, F K Friedman, et al.
Journal of Child and Adolescent Psychopharmacology|March 3, 2005
Concomitant pharmacotherapy among youths treated in routine psychiatric practiceFarifteh Firoozmand Duffy, William E Narrow, Donald S Rae, et al.
The New England Journal of Medicine|June 17, 2005
Prevalence and treatment of mental disorders, 1990 to 2003Ronald C Kessler, Olga Demler, Richard G Frank, et al.
Rand Health Quarterly|December 9, 2022
Availability and Accessibility of Mental Health Services in New York CityJoshua Breslau, Dionne Barnes-Proby, Mallika Bhandarkar, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1988
Preoperative combined modality therapy for stage III M0 non-small cell lung carcinomaM Pincus, S Reddy, M S Lee, et al.
Breast Disease|August 16, 2021
Correlation of manual semi-quantitative and automated quantitative Ki-67 proliferative index with OncotypeDXTM recurrence score in invasive breast carcinomaBrian S Finkelman, Amanda Meindl, Carissa LaBoy, et al.
The Journal of Clinical Psychiatry|June 1, 1992
Psychopharmacological screening criteria. APA Committee on Research on Psychiatric TreatmentsJ M Kane, D L Evans, S J Fiester, et al.
The American Journal of Psychiatry|November 1, 1992
A national study of psychiatrists' professional activitiesR A Dorwart, L R Chartock, T Dial, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Phase I dose escalation study of topotecan combined with alternating schedules of paclitaxel and carboplatin in advanced solid tumorsF R Dunphy, T L Dunleavy, B R Harrison, et al.
Pageof 223